Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus
Clinical trial NCT02143973 · COMPLETED
Trial details
- NCT number
- NCT02143973
- Sponsor
- Trevi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-01-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.